SEC Form 4 · accession 0000899243-16-011435
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E. Hughes
Officer — Chief Executive Officer · Director
Period of report
Jan 8, 2016
Accepted (ET)
Jan 8, 2016 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2016 | M | 10,000 | $0.75 | A | 21,320 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.75 | Jan 8, 2016 | M | 10,000 | D | — | Dec 15, 2018 | Common Stock | 10,000 | 43,928 | D |
Explanation of responses
- F1Fully vested.